Hepatitis Monthly

Published by: Kowsar

Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic Review

Khashayar Hesamizadeh 1 , 2 , Seyed Moayed Alavian 1 , 2 , Azar Najafi Tireh Shabankareh 3 and Heidar Sharafi 1 , 2 , *
Authors Information
1 Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Middle East Liver Diseases (MELD) Center, Tehran, IR Iran
3 Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: December 01, 2016, 16 (12); e42938
  • Published Online: November 19, 2016
  • Article Type: Review Article
  • Received: October 10, 2016
  • Accepted: November 13, 2016
  • DOI: 10.5812/hepatmon.42938

To Cite: Hesamizadeh K, Alavian S M, Najafi Tireh Shabankareh A, Sharafi H. Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic Review, Hepat Mon. 2016 ; 16(12):e42938. doi: 10.5812/hepatmon.42938.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Footnote
References
  • 1. Alavian S, Fallahian F. Epidemiology of Hepatitis C in Iran and the World. Shiraz E Med J. 2009; 10(4): 162-72
  • 2. Alavian SM, Tabatabaei SV, Mahboobi N. Epidemiology and risk factors of HCV infection among hemodialysis patients in countries of the Eastern Mediterranean Regional Office of WHO (EMRO): a quantitative review of literature. J Public Health. 2011; 19(2): 191-203[DOI]
  • 3. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57(4): 1333-42[DOI][PubMed]
  • 4. Lavanchy D. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepatitis. 1999; 6(1): 35-47[DOI]
  • 5. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011; 17(2): 107-15[DOI][PubMed]
  • 6. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med. 2005; 8(2): 84-90
  • 7. Alavian SM, Ahmadzad-Asl M, Lankarani KB, Shahbabaie MA, Bahrami Ahmadi A, Kabir A. Hepatitis C infection in the general population of Iran: a systematic review. Hepat Mon. 2009; 9(3): 211-23
  • 8. Alavian SM, Aalaei-Andabili SH. Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis. Hepat Mon. 2012; 12(4): 244-52[DOI][PubMed]
  • 9. Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013; 10(9): 553-62[DOI][PubMed]
  • 10. Alavian SM, Hajarizadeh B, Bagheri Lankarani K, Sharafi H, Ebrahimi Daryani N, Merat S. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepat Mon. : 40959[DOI]
  • 11. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014; 59(1): 318-27[DOI][PubMed]
  • 12. Sadeghi F, Salehi-Vaziri M, Almasi-Hashiani A, Gholami-Fesharaki M, Pakzad R, Alavian SM. Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis. Hepat Mon. 2016; 16(4): 35558[DOI][PubMed]
  • 13. Hesamizadeh K, Sharafi H, Rezaee-Zavareh MS, Behnava B, Alavian SM. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepat Mon. 2016; 16(4): 37089[DOI][PubMed]
  • 14. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001; 358(9286): 958-65[DOI][PubMed]
  • 15. Behnava B, Sharafi H, Keshvari M, Pouryasin A, Mehrnoush L, Salimi S, et al. The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C. Hepat Mon. 2016; 16(1): 32703[DOI][PubMed]
  • 16. The growing threats of hepatitis B and C in the Eastern Mediterranean region: a call for action 2009;
  • 17. Ramia S, Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis. 2006; 10(4): 272-7[DOI][PubMed]
  • 18. Ghaderi-Zefrehi H, Gholami-Fesharaki M, Sharafi H, Sadeghi F, Alavian SM. The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepat Mon. 2016; 16(9): 40357[DOI][PubMed]
  • 19. Khodabandehloo M, Roshani D. Prevalence of hepatitis C virus genotypes in Iranian patients: a systematic review and meta-analysis. Hepat Mon. 2014; 14(12): 22915[DOI][PubMed]
  • 20. Kabakci Alagoz G, Karatayli SC, Karatayli E, Celik E, Keskin O, Dinc B, et al. Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: performance of phylogenetic analysis of the NS5B, E1, and 5'UTR regions in genotyping efficiency. Turk J Gastroenterol. 2014; 25(4): 405-10[DOI][PubMed]
  • 21. Khan N, Akmal M, Hayat M, Umar M, Ullah A, Ahmed I, et al. Geographic distribution of hepatitis C virus genotypes in pakistan. Hepat Mon. 2014; 14(10): 20299[DOI][PubMed]
  • 22. Osoba AO. Hepatitis C virus genotypes in Saudi Arabia. Saudi Med J. 2002; 23(1): 7-12[PubMed]
  • 23. Bokharaei Salim F, Keyvani H, Amiri A, Jahanbakhsh Sefidi F, Shakeri R, Zamani F. Distribution of different hepatitis C virus genotypes in patients with hepatitis C virus infection. World J Gastroenterol. 2010; 16(16): 2005-9[DOI][PubMed]
  • 24. Taherkhani R, Farshadpour F. Epidemiology of hepatitis C virus in Iran. World J Gastroenterol. 2015; 21(38): 10790-810[DOI][PubMed]
  • 25. Murphy DG, Willems B, Deschenes M, Hilzenrat N, Mousseau R, Sabbah S. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. J Clin Microbiol. 2007; 45(4): 1102-12[DOI][PubMed]
  • 26. Ciccozzi M, Lo Presti A, Ciccaglione AR, Zehender G, Ciotti M. Phylogeny and phylodinamic of Hepatitis C in Italy. BMC Infect Dis. 2012; 12 Suppl 2: 5[DOI][PubMed]
  • 27. Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010; 8(5): 336-41[DOI][PubMed]
  • 28. Vandenbroucke JP, Elm EV, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. Ann Internal Med. 2007; 147(8): 163[DOI]
  • 29. Alfaro ME, Zoller S, Lutzoni F. Bayes or bootstrap? A simulation study comparing the performance of Bayesian Markov chain Monte Carlo sampling and bootstrapping in assessing phylogenetic confidence. Mol Biol Evol. 2003; 20(2): 255-66[DOI][PubMed]
  • 30. Kumar S, Stecher G, Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol. 2016; 33(7): 1870-4[DOI][PubMed]
  • 31. Aiyar A. The use of CLUSTAL W and CLUSTAL X for multiple sequence alignment. Methods Mol Biol. 2000; 132: 221-41[PubMed]
  • 32. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004; 32(5): 1792-7[DOI][PubMed]
  • 33. Samimi-Rad K, Asgari F, Nasiritoosi M, Esteghamati A, Azarkeyvan A, Eslami SM, et al. Patient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral Strains. Hepat Mon. 2013; 13(1): 7699[DOI][PubMed]
  • 34. Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol. 2004; 74(2): 246-52[DOI][PubMed]
  • 35. Samimi-Rad K, Nasiri Toosi M, Masoudi-Nejad A, Najafi A, Rahimnia R, Asgari F, et al. Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time. Arch Virol. 2012; 157(10): 1959-65[DOI][PubMed]
  • 36. Salehi Moghadam F, Mohebbi SR, Hosseini SM, Romani S, Mirtalebi H, Azimzadeh P, et al. Phylogenetic analysis of hepatitis C virus strains and risk factors associated with infection and viral subtypes among Iranian patients. J Med Virol. 2014; 86(8): 1342-9[DOI][PubMed]
  • 37. Sanders-Buell E, Rutvisuttinunt W, Todd CS, Nasir A, Bradfield A, Lei E, et al. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan. J Med Virol. 2013; 85(7): 1170-9[DOI][PubMed]
  • 38. Demetriou VL, van de Vijver DA, Cyprus H, Kostrikis LG. Molecular epidemiology of hepatitis C infection in Cyprus: evidence of polyphyletic infection. J Med Virol. 2009; 81(2): 238-48[DOI][PubMed]
  • 39. Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG, Cyprus IN, Kostrikis LG. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus. J Med Virol. 2010; 82(2): 263-70[DOI][PubMed]
  • 40. Brahim I, Akil A, Mtairag el M, Pouillot R, Malki AE, Nadir S, et al. Morocco underwent a drift of circulating hepatitis C virus subtypes in recent decades. Arch Virol. 2012; 157(3): 515-20[DOI][PubMed]
  • 41. Aziz H, Raza A, Murtaza S, Waheed Y, Khalid A, Irfan J, et al. Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Punjab Province in Pakistan and a phylogenetic analysis. Int J Infect Dis. 2013; 17(4): 247-53[DOI][PubMed]
  • 42. Djebbi A, Bahri O, Langar H, Sadraoui A, Mejri S, Triki H. Genetic variability of genotype 1 hepatitis C virus isolates from Tunisian haemophiliacs. New Microbiol. 2008; 31(4): 473-80[PubMed]
  • 43. Hmaied F, Ben Mamou M, Dubois M, Pasquier C, Sandres-Saune K, Rostaing L, et al. Determining the source of nosocomial transmission in hemodialysis units in Tunisia by sequencing NS5B and E2 sequences of HCV. J Med Virol. 2007; 79(8): 1089-94[DOI][PubMed]
  • 44. Cochrane A, Searle B, Hardie A, Robertson R, Delahooke T, Cameron S, et al. A genetic analysis of hepatitis C virus transmission between injection drug users. J Infect Dis. 2002; 186(9): 1212-21[DOI][PubMed]
  • 45. Harris KA, Teo CG. Diversity of Hepatitis C Virus Quasispecies Evaluated by Denaturing Gradient Gel Electrophoresis. Clin Diagnostic Laboratory Immunol. 2001; 8(1): 62-73[DOI]
  • 46. Cantaloube JF, Biagini P, Attoui H, Gallian P, de Micco P, de Lamballerie X. Evolution of hepatitis C virus in blood donors and their respective recipients. J Gen Virol. 2003; 84: 441-6[DOI][PubMed]
  • 47. Bracho MA, Gosalbes MJ, Blasco D, Moya A, Gonzalez-Candelas F. Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit. J Clin Microbiol. 2005; 43(6): 2750-5[DOI][PubMed]
  • 48. Lopez-Labrador FX, Bracho MA, Berenguer M, Coscolla M, Rayon JM, Prieto M, et al. Genetic similarity of hepatitis C virus and fibrosis progression in chronic and recurrent infection after liver transplantation. J Viral Hepat. 2006; 13(2): 104-15[DOI][PubMed]
  • 49. Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol. 2005; 76(3): 327-32[DOI][PubMed]
  • 50. Kchouk FH, Gorgi Y, Bouslama L, Sfar I, Ayari R, Khiri H, et al. Phylogenetic analysis of isolated HCV strains from tunisian hemodialysis patients. Viral Immunol. 2013; 26(1): 40-8[DOI][PubMed]
  • 51. Khan A, Tanaka Y, Azam Z, Abbas Z, Kurbanov F, Saleem U, et al. Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan. J Med Virol. 2009; 81(7): 1189-97[DOI][PubMed]
  • 52. Djebbi A, Mejri S, Thiers V, Triki H. Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients. Eur J Epidemiol. 2004; 19(6): 555-62[DOI][PubMed]
  • 53. Blackard JT, Sherman KE. Hepatitis C virus coinfection and superinfection. J Infect Dis. 2007; 195(4): 519-24[DOI][PubMed]
  • 54. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis. 2008; 8: 69[DOI][PubMed]
  • 55. Hussain A, Idrees M. The first complete genome sequence of HCV-1a from Pakistan and a phylogenetic analysis with complete genomes from the rest of the world. Virol J. 2013; 10: 211[DOI][PubMed]
  • 56. Alavian SM. Hepatitis C infection in Iran; A review article. Arch Clin Infect Dis. 2009; 4(1): 47-59
  • 57. Kadjbaf D, Keshvari M, Alavian SM, Pouryasin A, Behnava B, Salimi S, et al. The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C. Hepat Mon. 2016; 16(6): 37011[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments